Gene · 6716
Papers1,787
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 1,787
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Characterization of m6A modifiers and RNA modifications in uterine fibroids. | bioRxiv | 2023 | 37609293 | PubTator, text mining | PubMed |
| Aire drives steroid hormone biosynthesis by medullary thymic epithelial cells. | Sci Immunol | 2023 | 37595021 | PubTator, text mining | PubMed |
| Female Pattern Hair Loss: An Overview with Focus on the Genetics. | Genes (Basel) | 2023 | 37510231 | PubTator, text mining | PubMed |
| Biotechnological Applications of Mushrooms under the Water-Energy-Food Nexus: Crucial Aspects and Prospects from Farm to Pharmacy. | Foods | 2023 | 37509764 | PubTator, text mining | PubMed |
| Clinical characteristics and genetic expansion of 46,XY disorders of sex development children in a Chinese prospective study. | Endocr Connect | 2023 | 37493574 | PubTator, text mining | PubMed |
| Critical Evaluation of Transcripts and Long Noncoding RNA Expression Levels in Prostate Cancer Following Radical Prostatectomy. | Pathobiology | 2023 | 37463569 | PubTator, text mining | PubMed |
| Methods for Evaluating the Efficacy of Medical Castration: A Systematic Review. | Cancers (Basel) | 2023 | 37444589 | PubTator, text mining | PubMed |
| The role of 11-oxygenated androgens in prostate cancer. | Endocr Oncol | 2023 | 37434644 | PubTator, text mining | PubMed |
| Genetic reanalysis of patients with a difference of sex development carrying the NR5A1/SF-1 variant p.Gly146Ala has discovered other likely disease-causing variations. | PLoS One | 2023 | 37432935 | PubTator, text mining | PubMed |
| Use of 5-Alpha Reductase Inhibitors in Dermatology: A Narrative Review. | Dermatol Ther (Heidelb) | 2023 | 37432644 | PubTator, text mining | PubMed |
| Central serous chorioretinopathy: updates in the pathogenesis, diagnosis and therapeutic strategies. | Eye Vis (Lond) | 2023 | 37430344 | PubTator, text mining | PubMed |
| Intelligent nanotherapeutic strategies for the delivery of CRISPR system. | Acta Pharm Sin B | 2023 | 37425051 | PubTator, text mining | PubMed |
| Integrative analysis of circadian clock with prognostic and immunological biomarker identification in ovarian cancer. | Front Mol Biosci | 2023 | 37409345 | PubTator, text mining | PubMed |
| Androgen-regulated stromal complement component 7 (C7) suppresses prostate cancer growth. | Oncogene | 2023 | 37400528 | PubTator, text mining | PubMed |
| Plumbagin, a Natural Compound with Several Biological Effects and Anti-Inflammatory Properties. | Life (Basel) | 2023 | 37374085 | PubTator, text mining | PubMed |
| Effects of Androgen Treatment on Growth in Patients with 5-α-Reductase Type 2 Deficiency. | J Pers Med | 2023 | 37373981 | PubTator, text mining | PubMed |
| Bioinformatic analysis of gene expression data reveals Src family protein tyrosine kinases as key players in androgenetic alopecia. | Front Med (Lausanne) | 2023 | 37359019 | PubTator, text mining | PubMed |
Modulatory properties of Thespesia garckeana (F. Hoffm.) Exell & Hillc. Aqueous fruit extract on female rats reproductive hormones and tissues histology and potential inhibitory activity of its constituents against SRD5α2. | J Ethnopharmacol | 2023 | 37356746 | PubTator, text mining | PubMed |
| Applications of genomic research in pediatric endocrine diseases. | Clin Exp Pediatr | 2023 | 37321569 | PubTator, text mining | PubMed |
| Genotype-phenotype correlations, surgical selections, and postoperative complications of 5α-reductase 2 deficiency in 69 children with hypospadias. | Asian J Androl | 2023 | 37313883 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6716/papers?page=9